Listen
4 Ergebnisse
Filter
Einstellungen
Suchergebnisse
Veröffentlichung Bewertung von Transformationsprodukten bei der Trinkwasseraufbereitung(2014)Oxidative Transformationsprodukte von Spurenstoffen werden am Fallbeispiel PSM-Metaboliten auf ihr toxisches Potenzial untersucht. Im Labormaßstab werden Ozonung, Anreicherung und (gen)toxikologische Testung miteinander gekoppelt.
© Energie Wasser PraxisVeröffentlichung Integration von Geschlecht in die Forschung zu umweltbezogener Gesundheit. Ergebnisse des interdisziplinären Forschungsnetzwerks Geschlecht - Umwelt - Gesundheit (GeUmGe-NET)(2018) Bolte, Gabriele; David, Madlen; Debiak, Malgorzata; Kolossa-Gehring, MarikeDie umfassende Berücksichtigung von Geschlecht (biologische und soziale Dimensionen) in der Gesundheitsforschung ist essenziell, um Relevanz und Validität der Forschungsergebnisse zu erhöhen. Im Unterschied zu anderen Bereichen der Gesundheitsforschung fehlt bislang eine systematische Aufarbeitung des Forschungsstandes zur Bedeutung von Geschlecht bei umweltbezogener Gesundheit. In dem interdisziplinären Forschungsnetzwerk Geschlecht - Umwelt - Gesundheit (GeUmGe-NET) wurde in ausgewählten Themenfeldern der Forschungsbereiche Umwelttoxikologie, Umweltmedizin, Umweltepidemiologie und Public-Health-Forschung zu Umwelt und Gesundheit der aktuelle Stand zur Integration von Geschlechteraspekten bzw. Genderkonzepten systematisch erhoben. In allen Bereichen wurden Wissenslücken und Forschungsbedarfe identifiziert sowie Potenziale für methodische Weiterentwicklungen durch Nutzung von Genderkonzepten aufgezeigt. Mit dem Forschungsnetzwerk GeUmGe-NET wurde ein Dialog zwischen biomedizinisch bzw. Public-Health-orientierter Gesundheitsforschung und sozialwissenschaftlicher Genderforschung begonnen. Dieser Dialog ist weiterzuführen, insbesondere hinsichtlich der gemeinsamen Erprobung methodischer Innovationen bei Datenerhebung und Datenanalyse. Erkenntnisse aus dieser interdisziplinären Forschung sind relevant für die Praxisfelder umweltbezogener Gesundheitsschutz, Gesundheitsförderung, Umweltgerechtigkeit und umweltbezogene Gesundheitsberichterstattung. © Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018Veröffentlichung Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results(2021) Ougier, Eva; David, Madlen; Ganzleben, Catherine; Lecoq, Pierre; Kolossa-Gehring, Marike; Lange, RosaThe European Human Biomonitoring Initiative (HBM4EU1) has established a European Union-wide human biomonitoring (HBM) programme to generate knowledge on human internal exposure to chemical pollutants and their potential health impacts in Europe, in order to support policy makers' efforts to ensure chemical safety and improve health in Europe. A prioritisation strategy was necessary to determine and meet the most important needs of both policy makers and risk assessors, as well as common national needs of participating countries and a broad range of stakeholders. This strategy consisted of three mains steps: 1) mapping of knowledge gaps identified by policy makers, 2) prioritisation of substances using a scoring system, and 3) generation of a list of priority substances reflective of the scoring, as well as of public policy priorities and available resources. For the first step, relevant ministries and agencies at EU and national levels, as well as members of the Stakeholder Forum each nominated up to 5 substances/substance groups of concern for policy-makers. These nominations were collated into a preliminary list of 48 substances/substance groups, which was subsequently shortened to a list of 23 after considering the total number of nominations each substance/substance group received and the nature of the nominating entities. For the second step, a panel of 11 experts in epidemiology, toxicology, exposure sciences, and occupational and environmental health scored each of the substances/substance groups using prioritisation criteria including hazardous properties, exposure characteristics, and societal concern. The scores were used to rank the 23 substances/substance groups. In addition, substances were categorised according to the level of current knowledge about their hazards, extent of human exposure (through the availability of HBM data), regulatory status and availability of analytical methods for biomarker measurement. Finally, in addition to the ranking and categorisation of the substances, the resources available for the project and the alignment with the policy priorities at European level were considered to produce a final priority list of 9 substances/substance groups for research activities and surveys within the framework of the HBM4EU project. Quelle: © 2021 The Authors. Published by Elsevier GmbHVeröffentlichung The role of behavioral ecotoxicology in environmental protection(2021) Ford, Alex; Ågerstrand, Marlene; Brooks, Bryan W.; Duquesne, Sabine; Sahm, René; Gergs, René; Jacob, Stefanie; Maack, Gerd; Mohr, SilviaFor decades, we have known that chemicals affect human and wildlife behavior. Moreover, due to recent technological and computational advances, scientists are now increasingly aware that a wide variety of contaminants and other environmental stressors adversely affect organismal behavior and subsequent ecological outcomes in terrestrial and aquatic ecosystems. There is also a groundswell of concern that regulatory ecotoxicology does not adequately consider behavior, primarily due to a lack of standardized toxicity methods. This has, in turn, led to the exclusion of many behavioral ecotoxicology studies from chemical risk assessments. To improve understanding of the challenges and opportunities for behavioral ecotoxicology within regulatory toxicology/risk assessment, a unique workshop with international representatives from the fields of behavioral ecology, ecotoxicology, regulatory (eco)toxicology, neurotoxicology, test standardization, and risk assessment resulted in the formation of consensus perspectives and recommendations, which promise to serve as a roadmap to advance interfaces among the basic and translational sciences, and regulatory practices. © 2021 The Authors